Clinical Trial Update: Quality of Recovery After Reversal With Neostigmine or Sugammadex. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating recovery quality after reversal with neostigmine or sugammadex for incomplete reversal of neuromuscular block; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incomplete Reversal of Neuromuscular Block

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Stony Brook University | Conditions: Incomplete Reversal of Neuromuscular Block | Phase 4 | Status: COMPLETED | Results posted: 2020-05-22